Paper · 19795446
Beneficial and detrimental effects of human endogenous retroviruses.
Kurth R and 1 other. Int J Cancer, 2010. Cited by 98 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Beneficial and detrimental effects of human endogenous retroviruses. Papers, record 19795446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19795446
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endogenous Retroviruses | Major topic |
| Genome, Human | Major topic |
| Retroelements | Major topic |
| Animals | |
| Evolution, Molecular | |
| Gene Expression Regulation | |
| Humans | |
| Mutagenesis, Insertional | |
| Neoplasms | |
| Retroviridae |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,184,406 | Variations in blood levels of the anti-fusogenic endogenous retroviral protein suppressyn are associated with fetal growth outcome in preeclampsia. | Sci Rep | 2025 | https://conductscience.org/library/papers/41184406 | PubMed |
| 40,723,922 | Genetic Diversity in the Suppressyn Gene Sequence: From Polymorphisms to Loss-of-Function Mutations. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723922 | PubMed |
| 40,590,391 | The relationship between HERVs and exogenous viral infections: A focus on the value of HERVs in disease prediction and treatment. | Virulence | 2025 | https://conductscience.org/library/papers/40590391 | PubMed |
| 40,387,511 | Combination Therapy Approaches to Enhance the Efficacy of ERV-Targeting Vaccines in Cancer. | Cancer Immunol Res | 2025 | https://conductscience.org/library/papers/40387511 | PubMed |
| 40,360,436 | Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40360436 | PubMed |
| 39,684,434 | LINE-1-Induced Retrotransposition Affects Early Preimplantation Embryo DNA Integrity and Pluripotency. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684434 | PubMed |
| 38,540,701 | Species-Specific Transcription Factors Associated with Long Terminal Repeat Promoters of Endogenous Retroviruses: A Comprehensive Review. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540701 | PubMed |
| 38,413,664 | The human PTGR1 gene expression is controlled by TE-derived Z-DNA forming sequence cooperating with miR-6867-5p. | Sci Rep | 2024 | https://conductscience.org/library/papers/38413664 | PubMed |
| 38,159,236 | Human Endogenous Retroviruses in Diseases. | Subcell Biochem | 2023 | https://conductscience.org/library/papers/38159236 | PubMed |
| 38,002,309 | Controlling Trophoblast Cell Fusion in the Human Placenta-Transcriptional Regulation of Suppressyn, an Endogenous Inhibitor of Syncytin-1. | Biomolecules | 2023 | https://conductscience.org/library/papers/38002309 | PubMed |
1 to 10 of 70
See all 70 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19795446
GET https://conductscience.org/api/papers/v1/19795446/cited_by?page=2